Agranulocytosis
In case of agranulocytosis, the number of granulocytes in the blood is extremely low or even completely absent, which makes it very easy to be complicated with serious infection, serious condition, high mortality rate, and active rescue is needed. Before the advent of antibiotics, the mortality rate was as high as 90-95%. Since the application of antibiotics, it has dropped to 20%, but early diagnosis and early treatment are still needed.
-
Site of disease:
Spinal cord blood vessels -
Infectious :
Not contagious -
Frequent population:
A common cause is that the patient is sensitive to the drug (amino... -
Related symptoms:
Nausea high fever chills cyanosis high fever -
Concurrent disease:
Related Drugs
Recombinant human granulocyte-stimulating factor injection
Indication: 1 Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2 Promote the increase of neutrophil count after bone marrow transplantation. 3 Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, cyclical neutropenia
Manufacturer:
Changchun GeneScience Pharmaceutical Co., Ltd.